Abstract:Background: Patients with Alzheimer's disease (AD) often exhibit characteristic clinical manifestations, particularly neuropsychiatric symptoms. Previous studies have shown that white matter hyperintensity (WMH) is strongly associated with AD progression, as well as neuropsychiatric symptoms. The purpose of this study was to investigate the clinical and neuropsychological characteristics of AD patients with WMH. Methods: This retrospective study involved 104 18-fluorodeoxyglucose-positron emission computed tomography (18FDG-PET-CT)-defined AD patients treated at Tianjin Huanhu Hospital from January 2010 to December 2022. Cranial magnetic resonance imaging (MRI) provided semi-quantitative data on brain structure and WMH. Collect and analyze patient clinical data. Neuropsychological assessments were used to evaluate cognitive function and psychobehavioral traits. Results: Among the 104 patients, 66 were in the WMH group (63.5%) and 38 in the non-white matter hyperintensity (non-WMH) group (36.5%). There were no significant differences in gender, age, age of onset, education, BMI, smoking, drinking, diabetes, coronary heart disease, dementia family history, fasting blood glucose, total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C) between the two groups. The WMH group showed higher rates of hypertension, homocysteine (Hcy) levels, NPI, and CDR scores as compared to the non-WMH group (p < 0.05). MMSE and MoCA scores were significantly lower in the WMH group (p < 0.05). In the MMSE subitem analysis, patients in the WMH group showed a decrease in attention, recall, and language scores. In the MOCA subitem analysis, WMH patients had lower scores in executive function, naming, attention, language, abstraction, and orientation (p < 0.05). Furthermore, subgroup analysis of NPI showed a higher incidence of delusions, depression, and apathy in the WMH group (p < 0.05). According to the hierarchical analysis of mild, moderate and severe dementia groups, the hypertension, leukoencephalopathy, Hcy level, Fazekas total score, PWMH and DWMH scores in the severe dementia group were significantly higher than those in the mild and moderate dementia groups (p < 0.05). As the disease progresses, more and more patients show increased white matter hyperintensity. Conclusion: White matter lesions are closely correlated with cognitive decline and psychobehavioral symptoms in AD patients, and may be used as an indicator of disease progression. Priority should be given to early screening and prevention of WMH-related risk factors.

White Matter Hyperintensities in Cognitive Impairment with Lewy Body Disease: a Multicentre Study.

Study on the Relationship between White Matter Lesions and Cognitive Impairment

Impact of Different White Matter Hyperintensities Patterns on Cognition: A Cross-Sectional and Longitudinal Study.

The Influence of White Matter Hyperintensity on Cognitive Impairment in Parkinson's Disease.

White matter hyperintensities in mild lewy body dementia

Regional White Matter Hyperintensity Volume in Parkinson's Disease and Associations with the Motor Signs.

The clinical and neuropsychological profiles of Alzheimer's disease with white matter hyperintensity in North China

White matter hyperintensities and cholinergic degeneration as Lewy body disease

Abstract TP442: Periventricular Not Deep White Matter Hyperintensities Are Associated with Vascular Cognitive Impairment

Severity of White Matter Hyperintensities: Lesion Patterns, Cognition, and Microstructural Changes.

Impaired Structural Network Properties Caused by White Matter Hyperintensity Related to Cognitive Decline

Periventricular rather than deep white matter hyperintensities are associated with white matter lesion relevant vascular cognitive impairment

Characteristics of Cortical Atrophy and White Matter Lesions Between Dementia With Lewy Bodies and Alzheimer's Disease: A Case-Control Study

The Neuropsychological Profile of Mild Cognitive Impairment in Lewy Body Dementias

White Matter Hyperintensities-Related Cortical Changes and Correlation with Mild Behavioral Impairment.

White matter hyperintensity burden predicts cognitive but not motor decline in Parkinson's disease: results from the Ontario Neurodegenerative Diseases Research Initiative

White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts

Amnestic Mild Cognitive Impairment in Parkinson's Disease: White Matter Structural Changes and Mechanisms.

Decline in executive function in patients with white matter hyperintensities from the static and dynamic perspectives of amplitude of low-frequency fluctuations

THE CUMULATIVE SPATIAL DISTRIBUTION OF WHITE MATTER HYPERINTENSITIES AND ITS CRITICAL STAGE THAT AFFECTS COGNITION AND THE BRAIN IN NON-DEMENTED ELDERLY

Associations of White Matter Hyperintensities with Cognitive Decline: A Longitudinal Study